ArticleNature reviews electrical engineering2026
Engineering two-dimensional electronic biosensors.
Article in Nature reviews electrical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The combination of exceptional electrical, mechanical, geometrical and chemical properties of two-dimensional materials has enabled highly sensitive detection of biological and environmental signals and opened new frontiers in biosensing. Graphene has pioneered much of this progress, yet the broader landscape of two-dimensional materials, comprising hundreds of experimentally validated and thousands of theoretically predicted materials, offers vast, largely untapped potential. The field is now at a critical stage where device sensitivity must be matched by improvements in selectivity, stability, reproducibility and operation under physiological conditions. This Perspective reviews the current state-of-the-art in two-dimensional materials-based biosensors, highlighting their key advances and drawbacks. We argue that further progress will depend on linking biosensing performance more directly to the intrinsic structures and properties of individual materials. Emerging strategies to overcome persistent challenges, such as biocompatibility, selectivity, functionalization, drift, reproducibility and stability under physiological conditions will be central to translating laboratory demonstrations into reliable translational sensing technologies. The diversity of two-dimensional materials also creates opportunities to move beyond graphene and match specific material properties to unique sensing functions. Their integration into flexible and portable point-of-care devices would support applications ranging from continuous health monitoring to the Internet of Medical Things.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.